Premium
AUTHOR'S REPLY
Author(s) -
Colombo Mario
Publication year - 2000
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.2000.tb11637.x
Subject(s) - obstetrics and gynaecology , citation , library science , medicine , computer science , pregnancy , genetics , biology
Cent European J Urol. 2016; 69: 34 doi: 10.5173/ceju.2016.r105 First of all, we want to thank Prof. Mark Soloway for his comment on our article [1]. The benefit of laparoscopic radical cystectomy (LRC) with or without prostate capsule sparing (PCS) does not lie in the fact of the decrease in hospital stay when compared with open radical cystectomy (ORC) series. The true value of LRC lies in other aspects, such as decreased perioperative blood transfusion (PBT), less postoperative pain, and faster patient recovery. Nowadays, ORC is the standard treatment for localized muscle invasive bladder cancer. LRC and robot-assisted laparoscopic radical cystectomy (RRC) are feasible, but they are currently considered experimental therapies because of the limited number of cases reported, the absence of long-term oncologic and functional outcome data, and a possible selection bias [2]. Despite this fact, the numbers of series reporting perioperative outcomes and survival of LRC and RRC is increasing in the last decade. ORC is associated with a high rate of transfusion, ranging around 30% in different series [3], but there are a few studies evaluating the relationship between transfusion and survival after this procedure. These authors (JG Rivas, et al.) reported in 2014 a lower survival rate in patients who receive PBT after LRC. Also, we found a relationship between infectious postoperative complications and Juan Gómez Rivas, Sergio Alonso y Gregorio, Mario Álvarez-Maestro